This is a routine reaffirmation with zero new information. Monitor the next quarterly earnings release (Q2 2026) for any updates to revenue and EPS trajectory. No immediate trading catalyst.
IONS drugs
IONS drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jul 10 $58.25entry
- T+1 · 4mo ago −2.93%α −2.15% · $56.54
- T+5 · 4mo ago −6.18%α −5.62% · $54.65
- T+20 · 3mo ago −2.90%α −5.33% · $56.56
- T+60 · 6w ago −25.32%α −27.96% · $43.50
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Ionis Pharmaceuticals filed an 8-K reaffirming its previously announced FY2026 financial guidance from April 29, 2026, with no changes. The filing contains no new financial data, preliminary results, or material updates, only a confirmation of prior guidance.
Key Facts
- Ionis reaffirms previously announced FY2026 financial guidance unchanged from April 29, 2026 Q1 earnings release
- No new financial metrics, preliminary results, or guidance revisions disclosed
- Filing contains only a brief Regulation FD disclosure with forward-looking statements
Financial Impact
No new financial data disclosed; guidance unchanged from prior guidance (amounts not republished in this filing)
Risk Factors
- No new information reduces near-term volatility; stock may drift with sector
- Forward-looking statements subject to clinical and regulatory risks in Ionis' pipeline
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001140361-26-028154 |
| Document: 0001140361-26-028154-index-headers.html | 0001140361-26-028154 |
| Document: 0001140361-26-028154-index.html | 0001140361-26-028154 |
| Document: 0001140361-26-028154.txt | 0001140361-26-028154 |
Track record
26 reports on IONS
7 of 10 bullish or bearish reports moved the stock their way by T+5. Best: +32.25% at T+60 after the Jul 9, 2026 report. 9 of 10 went positive at some point.
Filters
- Nov 9, 20267d ago 8-K Bearish 6/10 Entry $31.00 to $28.01 Now $28.01 +9.65% ▲ +9.65% +7.95% vs SPY
- Oct 27, 202620d ago Institutional Cluster Mixed 4/10 Entry $44.90 to $40.15 Now $28.01 −37.62% ▼ −10.58% −9.87% vs SPY
- Oct 23, 202624d ago 8-K Bullish 7/10 Entry $42.93 to $43.52 Now $28.01 −34.75% ▲ +1.37% +1.93% vs SPY
- Oct 21, 202626d ago 8-K Bullish 7/10 Entry $43.91 to $44.39 Now $28.01 −36.21% ▲ +1.09% +0.39% vs SPY
- Oct 21, 202626d ago Institutional Cluster Mixed 3/10 Entry $43.91 to $44.39 Now $28.01 −36.21% ▲ +1.09% +0.39% vs SPY
- Sep 23, 20267w ago 8-K Bullish 7/10 Entry $43.93 to $44.65 Now $28.01 −36.24% ▲ +1.64% +2.31% vs SPY
- Sep 4, 202610w ago 8-K Bearish 7/10 Entry $56.71 to $47.25 Now $28.01 +50.61% ▲ +16.68% +15.56% vs SPY
- Sep 4, 202610w ago 8-K Bullish 7/10 Entry $58.09 to $51.44 Now $28.01 −51.78% ▼ −11.45% −10.24% vs SPY
- Jul 31, 202615w ago Insider Buy Neutral 4/10 Entry $54.49 to $56.94 Now $28.01 −48.60% ▲ +4.50% +2.47% vs SPY
- Jul 29, 202615w ago 8-K Neutral 5/10 Entry $54.04 to $54.19 Now $28.01 −48.17% ▲ +0.28% −5.25% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers